Asthma Therapeutics Market Size, Share, Analysis, Trends, Growth, 2032

Asthma Therapeutics Market

Asthma Therapeutics Market - By Drug Class (Bronchodilators, Anti-Inflammatory, and Combination Therapy), By Product (Inhalers and Nebulizers), By Route Of Administration (Inhaled, Oral, and Others), And By Region - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024 - 2032-

Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-2972 Published Date: Oct-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 27.59 Billion USD 46.83 Billion 5.4% 2023

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Asthma Therapeutics Market, 2015–2025 (USD Billion)
    • 2.2. Asthma Therapeutics Market: Snapshot
  • Chapter 3. Global Asthma Therapeutics Market– Industry Analysis
    • 3.1. Asthma Therapeutics Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Surging requirement of improving the clinical treatment methods with the perspective of curbing COVID-19 epidemic is likely to result in the market expansion over the forthcoming years.
      • 3.2.2. With majority of governments taking initiatives for creating awareness among the population pertaining to occurrence of asthma, the market is anticipated to gain traction over the ensuing years.
    • 3.3. Porter’s Five Forces Analysis
    • 3.4. Market Attractiveness Analysis
      • 3.4.1. Market attractiveness analysis By Drug Class
      • 3.4.2. Market attractiveness analysis By Route of Administration
      • 3.4.3. Market attractiveness analysis By Product
  • Chapter 4. Global Asthma Therapeutics Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Asthma Therapeutics Market: company market share, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Product launches
      • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Asthma Therapeutics Market– Drug Class Analysis
    • 5.1. Global Asthma Therapeutics Market overview: By Drug Class
      • 5.1.1. Global Asthma Therapeutics Market share, By Drug Class , 2019 and 2025
    • 5.2. Anti-inflammatory
      • 5.2.1. Global Asthma Therapeutics Market By Anti-inflammatory , 2015–2025 (USD Billion)
    • 5.3. Combination Therapy
      • 5.3.1. Global Asthma Therapeutics Market By Combination Therapy, 2015–2025 (USD Billion)
    • 5.4. Bronchodilators
      • 5.4.1. Global Asthma Therapeutics Market By Bronchodilators , 2015–2025 (USD Billion)
  • Chapter 6. Global Asthma Therapeutics Market– Route of Administration Analysis
    • 6.1. Global Asthma Therapeutics Market overview: By Route of Administration
      • 6.1.1. Global Asthma Therapeutics Market share, By Route of Administration , 2019 and 2025
    • 6.2. Inhaled
      • 6.2.1. Global Asthma Therapeutics Market By Inhaled, 2015–2025 (USD Billion)
    • 6.3. Oral
      • 6.3.1. Global Asthma Therapeutics Market By Oral, 2015–2025 (USD Billion)
    • 6.4. Others
      • 6.4.1.1. Global Asthma Therapeutics Market By Others, 2015–2025 (USD Billion)
  • Chapter 7. Global Asthma Therapeutics Market– Product Analysis
    • 7.1. Global Asthma Therapeutics Market overview: By Product
      • 7.1.1. Global Asthma Therapeutics Market share, By Product , 2019 and 2025
    • 7.2. Inhalers
      • 7.2.1. Global Asthma Therapeutics Market By Inhalers, 2015–2025 (USD Billion)
    • 7.3. Nebulizers
      • 7.3.1. Global Asthma Therapeutics Market By Nebulizers, 2015–2025 (USD Billion)
  • Chapter 8. Company Profiles
    • 8.1. Philips Healthcare
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Product Portfolio
      • 8.1.4. Business Strategy
      • 8.1.5. Recent Developments
    • 8.2. AstraZeneca Plc
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Product Portfolio
      • 8.2.4. Business Strategy
      • 8.2.5. Recent Developments
    • 8.3. GlaxoSmithKline Plc
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Product Portfolio
      • 8.3.4. Business Strategy
      • 8.3.5. Recent Developments
    • 8.4. Teva Pharmaceutical Industries Ltd.
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Product Portfolio
      • 8.4.4. Business Strategy
      • 8.4.5. Recent Developments
    • 8.5. CareFusion Corporation
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Product Portfolio
      • 8.5.4. Business Strategy
      • 8.5.5. Recent Development
    • 8.6. Sanofi-Aventis SA
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Product Portfolio
      • 8.6.4. Business Strategy
      • 8.6.5. Recent Development
    • 8.7. Boehringer Ingelheim GmbH
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Product Portfolio
      • 8.7.4. Business Strategy
      • 8.7.5. Recent Development
    • 8.8. Sunovion Pharmaceuticals, Inc.
      • 8.8.1. Overview
      • 8.8.2. Financials
      • 8.8.3. Product Portfolio
      • 8.8.4. Business Strategy
      • 8.8.5. Recent Development
    • 8.9. Merck & Co., Inc.
      • 8.9.1. Overview
      • 8.9.2. Financials
      • 8.9.3. Product Portfolio
      • 8.9.4. Business Strategy
      • 8.9.5. Recent Development
    • 8.10. Roche Diagnostics
      • 8.10.1. Overview
      • 8.10.2. Financials
      • 8.10.3. Product Portfolio
      • 8.10.4. Business Strategy
      • 8.10.5. Recent Development

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Global Asthma  Therapeutics Market, 2015–2025 (USD Billion)
4. Porter’s Five Forces Analysis
5. Global Asthma  Therapeutics Market attractiveness, By Drug Class  
6. Global Asthma  Therapeutics Market attractiveness, By Route of Administration 
7. Global Asthma  Therapeutics Market attractiveness, By Product 
8. Global Asthma  Therapeutics Market Share by Drug Class  ,2019 and 2025 (USD Billion)
9. Global Asthma  Therapeutics Market by Anti-inflammatory ,2015–2025 (USD Billion)
10. Global Asthma  Therapeutics Market by Combination Therapy ,2015–2025 (USD Billion)
11. Global Asthma  Therapeutics Market by Bronchodilators ,2015–2025 (USD Billion)
12. Global Asthma  Therapeutics Market Share by Route of Administration ,2019 and 2025 (USD Billion)
13. Global Asthma  Therapeutics Market by Inhaled,2015–2025 (USD Billion)
14. Global Asthma  Therapeutics Market by Oral,2015–2025 (USD Billion)
15. Global Asthma  Therapeutics Market by Others,2015–2025 (USD Billion)
16. Global Asthma  Therapeutics Market Share by Product ,2019 and 2025 (USD Billion)
17. Global Asthma  Therapeutics Market by Inhalers,2015–2025 (USD Billion)
18. Global Asthma  Therapeutics Market by Nebulizers,2015–2025 (USD Billion)
19. Global Asthma  Therapeutics Market share, by Region, 2019 and 2025
20. North America Asthma  Therapeutics Market, 2015–2025 (USD Billion)
21. Europe Asthma  Therapeutics Market, 2015–2025 (USD Billion)
22. Asia Pacific Asthma  Therapeutics Market, 2015–2025 (USD Billion)
23. Latin America Asthma  Therapeutics Market, 2015–2025 (USD Billion)
24. The Middle East and Africa Asthma  Therapeutics Market, 2015–2025 (USD Billion)
 


Table Of Tables

List of Tables

1. Global Asthma  Therapeutics Market: snapshot
2. Drivers of the Asthma  Therapeutics Market: impact analysis
3. North America Asthma  Therapeutics Market revenue, By Drug Class  , 2015–2025 (USD Billion)
4. North America Asthma  Therapeutics Market revenue, By Route of Administration , 2015–2025 (USD Billion)
5. North America Asthma  Therapeutics Market revenue, By Product , 2015–2025 (USD Billion)
6. The U.S. Asthma  Therapeutics Market revenue, By Drug Class  , 2015–2025 (USD Billion)
7. The U.S. Asthma  Therapeutics Market revenue, By Route of Administration , 2015–2025 (USD Billion)
8. The U.S. Asthma  Therapeutics Market revenue, By Product , 2015–2025 (USD Billion)
9. Rest of North America Asthma  Therapeutics Market revenue, By Drug Class  , 2015–2025 (USD Billion)
10. Rest of North America Asthma  Therapeutics Market revenue, By Route of Administration , 2015–2025 (USD Billion)
11. Rest of North America Asthma  Therapeutics Market revenue, By Product , 2015–2025 (USD Billion)
12. Europe Asthma  Therapeutics Market revenue, By Drug Class  , 2015–2025 (USD Billion)
13. Europe Asthma  Therapeutics Market revenue, By Route of Administration , 2015–2025 (USD Billion)
14. Europe Asthma  Therapeutics Market revenue, By Product , 2015–2025 (USD Billion)
15. UK Asthma  Therapeutics Market revenue, By Drug Class  , 2015–2025 (USD Billion)
16. UK Asthma  Therapeutics Market revenue, By Route of Administration , 2015–2025 (USD Billion)
17. UK Asthma  Therapeutics Market revenue, By Product , 2015–2025 (USD Billion)
18. France Asthma  Therapeutics Market revenue, By Drug Class  , 2015–2025 (USD Billion)
19. France Asthma  Therapeutics Market revenue, By Route of Administration , 2015–2025 (USD Billion)
20. France Asthma  Therapeutics Market revenue, By Product , 2015–2025 (USD Billion)
21. Germany Asthma  Therapeutics Market revenue, By Drug Class  , 2015–2025 (USD Billion)
22. Germany Asthma  Therapeutics Market revenue, By Route of Administration , 2015–2025 (USD Billion)
23. Germany Asthma  Therapeutics Market revenue, By Product , 2015–2025 (USD Billion)
24. Rest of Europe Asthma  Therapeutics Market revenue, By Drug Class  , 2015–2025 (USD Billion)
25. Rest of Europe  Asthma  Therapeutics Market revenue, By Route of Administration , 2015–2025 (USD Billion)
26. Rest of Europe Asthma  Therapeutics Market revenue, By Product , 2015–2025 (USD Billion)
27. Asia Pacific Asthma  Therapeutics Market revenue, By Drug Class  , 2015–2025 (USD Billion)
28. Asia Pacific Asthma  Therapeutics Market revenue, By Route of Administration , 2015–2025 (USD Billion)
29. Asia Pacific Asthma  Therapeutics Market revenue, By Product , 2015–2025 (USD Billion)
30. China Asthma  Therapeutics Market revenue, By Drug Class  , 2015–2025 (USD Billion)
31. China Asthma  Therapeutics Market revenue, By Route of Administration , 2015–2025 (USD Billion)
32. China Asthma  Therapeutics Market revenue, By Product , 2015–2025 (USD Billion)
33. Japan Asthma  Therapeutics Market revenue, By Drug Class  , 2015–2025 (USD Billion)
34. Japan Asthma  Therapeutics Market revenue, By Route of Administration , 2015–2025 (USD Billion)
35.  Japan Asthma  Therapeutics Market revenue, By Product , 2015–2025 (USD Billion)
36. India Asthma  Therapeutics Market revenue, By Drug Class  , 2015–2025 (USD Billion)
37. India Asthma  Therapeutics Market revenue, By Route of Administration , 2015–2025 (USD Billion)
38. India Asthma  Therapeutics Market revenue, By Product , 2015–2025 (USD Billion)
39. Rest of Asia Pacific Asthma  Therapeutics Market revenue, By Drug Class  , 2015–2025 (USD Billion)
40. Rest of Asia Pacific Asthma  Therapeutics Market revenue, By Route of Administration , 2015–2025 (USD Billion)
41. Rest of Asia Pacific Asthma  Therapeutics Market revenue, By Product , 2015–2025 (USD Billion)
42. Latin America Asthma  Therapeutics Market revenue, By Drug Class  , 2015–2025 (USD Billion)
43.  Latin  America Asthma  Therapeutics Market revenue, By Route of Administration , 2015–2025 (USD Billion)
44. Latin America Asthma  Therapeutics Market revenue, By Product , 2015–2025 (USD Billion)
45. Brazil Asthma  Therapeutics Market revenue, By Drug Class  , 2015–2025 (USD Billion)
46. Brazil Asthma  Therapeutics Market revenue, By Route of Administration , 2015–2025 (USD Billion)
47. Brazil Asthma  Therapeutics Market revenue, By Product , 2015–2025 (USD Billion)
48. Rest of Latin America Asthma  Therapeutics Market revenue, By Drug Class  , 2015–2025 (USD Billion)
49. Rest of Latin America Asthma  Therapeutics Market revenue, By Route of Administration , 2015–2025 (USD Billion)
50. Rest of Latin America Asthma  Therapeutics Market revenue, By Product , 2015–2025 (USD Billion)
51. The Middle East and Africa Asthma  Therapeutics Market revenue, By Drug Class  , 2015–2025 (USD Billion)
52. The Middle East and Africa Asthma  Therapeutics Market revenue, By Route of Administration , 2015–2025 (USD Billion)
53. The Middle East and Africa Asthma  Therapeutics Market revenue, By Product , 2015–2025 (USD Billion)
54. Saudi Arabia Asthma  Therapeutics Market revenue, By Drug Class  , 2015–2025 (USD Billion)
55. Saudi Arabia Asthma  Therapeutics Market revenue, By Route of Administration , 2015–2025 (USD Billion)
56. Saudi Arabia Asthma  Therapeutics Market revenue, By Product , 2015–2025 (USD Billion)
57. South Africa Asthma  Therapeutics Market revenue, By Drug Class  , 2015–2025 (USD Billion)
58. South Africa Asthma  Therapeutics Market revenue, By Route of Administration , 2015–2025 (USD Billion)
59. South Africa Asthma  Therapeutics Market revenue, By Product , 2015–2025 (USD Billion)
60. Rest of the Middle East & Africa Asthma  Therapeutics Market revenue, By Drug Class  , 2015–2025 (USD Billion)
61. Rest of the Middle East & Africa Asthma Therapeutics Market revenue, By Route of Administration , 2015–2025 (USD Billion)
62. Rest of the Middle East & Africa Asthma  Therapeutics Market revenue, By Product , 2015–2025 (USD Billion)


 
 

Methodology

FrequentlyAsked Questions

Surging proportion of pollution levels and alterations in the lifestyle patterns will boost the market trends. In addition to this, a prominent increase in the smoker proportion will result in the business growth in the years ahead.  Apparently, launching of low cost generic drugs as well as its approval by regulatory bodies such as the U.S. FDA is predicted to steer the growth of asthma therapeutics market over the years ahead. 

According to Zion market research, the global Asthma Therapeutics Market was worth USD 27.59 Billion in 2023. The market is forecast to reach USD 46.83 Billion by 2032, growing at a compound annual growth rate (CAGR) of 5.4% during the forecast period 2024-2032. 

North America is likely to make noteworthy contributions towards overall market revenue during 2024 – 2032. The surge in the expansion of market in the sub-continent over the estimated timespan is due to prominent increment in the awareness about different kinds of medical treatments for asthma.

The key players profiled in the report include Sunovion Pharmaceuticals, Inc., CareFusion Corporation, Boehringer Ingelheim GmbH, Merck & Co., Inc., Philips Healthcare, AstraZeneca Plc, Sanofi-Aventis SA, GlaxoSmithKline Plc, Teva Pharmaceutical Industries Ltd., and Roche Diagnostics.

Choose License Type

  • zion payment modes

List of Contents

Market InsightsOverviewReport ScopeGrowth DriversMarket:SegmentationMarket:Regional InsightsMarket:Competitive SpaceThe global asthma therapeutics market is segmented as follows:

RelatedNews

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

How it Works?

Our Company

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed